Search research articles
Contact Us
Filters
Showing results (1-10 of 127) with videos related to
Page
of 13
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
November 7, 2024
Highlights in metastatic prostate cancer from the European Society for Medical Oncology Congress 2024: commentary
Pedro C Barata
The Oncologist
|
June 29, 2026
Modernizing Disease Assessment in Prostate Cancer Trials: The Prostate Cancer Working Group 4 Framework
Miguel Zugman, Pedro C Barata
Clinical Advances in Hematology & Oncology : H&O
|
June 12, 2026
Clinical response with cabozantinib plus nivolumab, a first-line therapy in advanced renal cell carcinoma: a clinical case report
Pedro C Barata, Ivan Macharashvili
JAMA Network Open
|
May 8, 2025
Combination Therapy in Metastatic Hormone-Sensitive Prostate Cancer-Are We Moving Fast Enough?
Pedro C Barata, Jorge A Garcia
Cancer
|
April 2, 2019
Metastatic castration-sensitive prostate cancer: Abiraterone, docetaxel, or…
Pedro C Barata, A Oliver Sartor
CA: a Cancer Journal for Clinicians
|
September 30, 2017
Treatment of renal cell carcinoma: Current status and future directions
Pedro C Barata, Brian I Rini
European Urology
|
December 20, 2025
Re: Final Overall Survival and Safety Analyses of the Phase III PSMAfore Trial of [<sup>177</sup>Lu]Lu-PSMA-617 Versus Change of Androgen Receptor Pathway Inhibitor in Taxane-Naive Patients with Metastatic Castration-Resistant Prostate Cancer
Pedro C Barata, Abby L Grier
CA: a Cancer Journal for Clinicians
|
December 13, 2025
Consensus and controversy in advanced urologic cancers: Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025
Albert Jang, Yousef Zakharia, Pedro C Barata
JAMA Network Open
|
December 9, 2024
In the Era of Treatment Intensification for Prostate Cancer, Why Are Some Living in the Past?
Jason R Brown, Neal Shore, Pedro C Barata
European Urology Focus
|
January 21, 2025
Enhancing the Immunogenicity of Nivolumab plus Ipilimumab with Live Bacterial Supplementation in Metastatic Renal Cell Carcinoma
Kevin K Zarrabi, Ulka Vaishampayan, Pedro C Barata
Page
of 13
Search research articles
Search
Showing results (1-10 of 127) with videos related to
Sort By:
Page
of 13
Clinical Advances in Hematology & Oncology : H&O
|
November 7, 2024
Highlights in metastatic prostate cancer from the European Society for Medical Oncology Congress 2024: commentary
Pedro C Barata
The Oncologist
|
June 29, 2026
Modernizing Disease Assessment in Prostate Cancer Trials: The Prostate Cancer Working Group 4 Framework
Miguel Zugman, Pedro C Barata
Clinical Advances in Hematology & Oncology : H&O
|
June 12, 2026
Clinical response with cabozantinib plus nivolumab, a first-line therapy in advanced renal cell carcinoma: a clinical case report
Pedro C Barata, Ivan Macharashvili
JAMA Network Open
|
May 8, 2025
Combination Therapy in Metastatic Hormone-Sensitive Prostate Cancer-Are We Moving Fast Enough?
Pedro C Barata, Jorge A Garcia
Cancer
|
April 2, 2019
Metastatic castration-sensitive prostate cancer: Abiraterone, docetaxel, or…
Pedro C Barata, A Oliver Sartor
CA: a Cancer Journal for Clinicians
|
September 30, 2017
Treatment of renal cell carcinoma: Current status and future directions
Pedro C Barata, Brian I Rini
European Urology
|
December 20, 2025
Re: Final Overall Survival and Safety Analyses of the Phase III PSMAfore Trial of [<sup>177</sup>Lu]Lu-PSMA-617 Versus Change of Androgen Receptor Pathway Inhibitor in Taxane-Naive Patients with Metastatic Castration-Resistant Prostate Cancer
Pedro C Barata, Abby L Grier
CA: a Cancer Journal for Clinicians
|
December 13, 2025
Consensus and controversy in advanced urologic cancers: Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025
Albert Jang, Yousef Zakharia, Pedro C Barata
JAMA Network Open
|
December 9, 2024
In the Era of Treatment Intensification for Prostate Cancer, Why Are Some Living in the Past?
Jason R Brown, Neal Shore, Pedro C Barata
European Urology Focus
|
January 21, 2025
Enhancing the Immunogenicity of Nivolumab plus Ipilimumab with Live Bacterial Supplementation in Metastatic Renal Cell Carcinoma
Kevin K Zarrabi, Ulka Vaishampayan, Pedro C Barata
Page
of 13